Featured,Spotlight Stock,Trends & Articles PSYC Partners With The Spore Group to Start Psychedelic Focused Events and Conferences By Dennis Mutua May 25, 2022 PSYC Corp. (OTCMKTS: PSYC) which operates Psychedelic Spotlight-a digital media outlet focusing on psychedelics news and information across the psychedelic medicine sector has entered into a partnership with The Spore Group (TSG) ...
Featured,Trends & Articles Oregon Adopts First Set of Therapeutic Psilocybin Measures By Dennis Mutua May 23, 2022 A few days ago, the Oregon Health Authority released a set of rules governing products testing and training programs for Oregon’s therapeutic psilocybin program which is slated to start next year. Back in February, the Oregon...
Featured,Trends & Articles CSIRO Begins Research and Development Activities on Medicinal Psychedelics By Dennis Mutua May 18, 2022 Australia based Commonwealth Scientific and Industrial Research Organization (CSIRO) says that it has started working with local biotechnology and pharmaceutical companies to improve existing psychedelics products and develop new ...
Featured,Spotlight Stock Numinus Wellness Granted Approval by Health Canada SAP to Provide Psychedelic-Assisted Treatment By Dennis Mutua May 17, 2022 Mental health and wellness company combining the practices of administering psychedelic medicine with holistic integrated psychotherapy Numinus Wellness Inc. (TSE: NUMI) (OTCMKTS: NUMIF) announced having received a regulatory appr...
Featured,Trends & Articles Ketamine Wellness Centers Inks Partnership Deal With the Veterans Administration in Arizona By Dennis Mutua May 16, 2022 Largest ketamine therapy provider in the United States offering infusions for depressions, chronic pains, anxiety among others Ketamine Wellness Centers (KWC) entered into a partnership deal with the Veterans Administration (VA) i...
Featured,Spotlight Stock,Trends & Articles Mindset Progresses its Lead Clinical Candidate MSP-1014 Towards Human Clinical Trials By Dennis Mutua May 13, 2022 Drug discovery and development company specializing on developing optimized and patentable next generation psychedelics medicines to treat neurological and psychiatrist disorders with unmet conditions Mindset Pharma Inc. (CSE: MSE...
Featured,Spotlight Stock,Trends & Articles Halucenex Granted Psilocybe Cubensis Import Permit by Health Canada By Dennis Mutua May 11, 2022 Life sciences development company focusing on performing psychedelic-assisted psychotherapy and clinical research Halucenex Life Sciences Inc. announced having secured a permit to import one kilogram of psilocybe cubensis to refin...
Featured,Trends & Articles New York Legislators Proposes Bills to Decriminalize Psychedelics By Dennis Mutua May 09, 2022 New York legislators have come up with several bills which are seeking to decriminalize use of psychedelic substances across the state. The bills were introduced late last week. Psychedelics is currently considered a Schedule I co...